Agloe Capital

Mallinckrodt PLC (NYSE: MNK), a developer of branded and generic specialty pharmaceutical products and therapies, is a popular stock among short sellers. Back in January, Martin Shkreli explained to Benzinga why a Federal Trade Commission lawsuit against the company is justified. Prior to that,...